Back to Learning Center Videos

Renal Denervation is Still Alive

Piedmont Heart interventional cardiologists discuss the latest outlook for using renal denervation to treat hypertension at the Napa Valley Cardiology Conference in June 2018.  Dr. David Kandzari, just back from EuroPCR 2018 where he presented results from the SPYRAL HTN trial, talked about what has changed since an earlier trial of Medtronic’s Symplicity Renal Denervation System failed to meet its primary endpoint, and the current, more positive implications for patient care.

Piedmont MyChart

Download Piedmont MyChart

  • Connect with your care team
  • See your test results
  • Request Rx refills
  • eCheck-in before you walk in 

Download the app today!

Get Piedmont MyChart on Google Play Get Piedmont Mychart on iTunes App Store